These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 16265556)

  • 61. Autonomic dysfunction and beta blocker therapy in Chagas heart disease.
    Bestetti RB; Cardinalli-Neto A
    Clinics (Sao Paulo); 2013; 68(2):275-6. PubMed ID: 23525327
    [No Abstract]   [Full Text] [Related]  

  • 62. [Beta-receptor blockers in fresh myocardial infarct].
    Langenfeld H
    Dtsch Med Wochenschr; 1993 Oct; 118(43):1569-74. PubMed ID: 7900982
    [No Abstract]   [Full Text] [Related]  

  • 63. Short-acting beta-adrenergic blockade as initial drug therapy in pheochromocytoma.
    Mihm FG; Sandhu JS; Brown MD; Rosenthal MH
    Crit Care Med; 1990 Jun; 18(6):673-4. PubMed ID: 1971559
    [No Abstract]   [Full Text] [Related]  

  • 64. Use of esmolol during intraoperative atrioventricular rhythm.
    James MF; Thomas HM
    Anaesth Intensive Care; 1996 Aug; 24(4):492-5. PubMed ID: 8862650
    [No Abstract]   [Full Text] [Related]  

  • 65. Beta blockade with nadolol in patient with congestive heart-failure.
    Vukovich R; Sasahara A; Sanchez-Zambrano S; Belko J
    Lancet; 1978 Jan; 1(8056):162-3. PubMed ID: 87607
    [No Abstract]   [Full Text] [Related]  

  • 66. Esmolol in the treatment of severe arrhythmia after acute trichloroethylene poisoning.
    Mortiz F; de La Chapelle A; Bauer F; Leroy JP; Goullé JP; Bonmarchand G
    Intensive Care Med; 2000 Feb; 26(2):256. PubMed ID: 10784325
    [No Abstract]   [Full Text] [Related]  

  • 67. Refractory arrhythmia in the presence of congestive failure: successful beta sympatholytic treatment.
    Vukovich RA; Sanchez-Zambrano S; Sasahara AA; Belko J
    Am Heart J; 1979 Sep; 98(3):399-400. PubMed ID: 38660
    [No Abstract]   [Full Text] [Related]  

  • 68. Clinical signs, diagnostics and successful treatment of a myocarditis in an adult chimpanzee (Pan troglodytes).
    van Zijll Langhout M; Wolters M; Horvath KM; Thiesbrummel H; Smits P; van Bolhuis H; van der Hulst V; Riezebos R
    J Med Primatol; 2017 Oct; 46(5):263-266. PubMed ID: 28523858
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Professor Peter Sleight's reflections on the use of beta-blocking agents after myocardial infarction.
    Sleight P
    Am Heart J; 1997 Aug; 134(2 Pt 2):S15-20. PubMed ID: 9313619
    [No Abstract]   [Full Text] [Related]  

  • 70. Rhythm disturbances with risk of heart failure in newborns.
    Fekete FP; Faller K; Szabolcs J
    Acta Paediatr Hung; 1990; 30(1):3-16. PubMed ID: 1969287
    [No Abstract]   [Full Text] [Related]  

  • 71. [Beta-blockers in cardiac arrhythmias, anxiety and stress].
    Collignon P
    Rev Med Liege; 1981 Oct; 36 Suppl 1():26-30. PubMed ID: 6119756
    [No Abstract]   [Full Text] [Related]  

  • 72. [Urban & Vogel Robert Koch Award for carvedilol].
    Holubarsch CJ
    Herz; 2002 Aug; 27 Suppl 1():4-5. PubMed ID: 12229257
    [No Abstract]   [Full Text] [Related]  

  • 73. Arrhythmias after infarction.
    Muller JE
    Ann Intern Med; 1972 Apr; 76(4):669-70. PubMed ID: 4640329
    [No Abstract]   [Full Text] [Related]  

  • 74. Carvedilol. A wide therapeutic potential in cardiovascular syndromes. Proceedings of a satellite symposium organized by the International Institute for Therapeutic Research (ICIT). Scheveningen, The Netherlands, August 23, 1991.
    Cardiology; 1993; 82 Suppl 3():1-58. PubMed ID: 8221744
    [No Abstract]   [Full Text] [Related]  

  • 75. Effect of carvedilol on atrial excitation-contraction coupling, Ca
    Martinez-Hernandez E; Blatter LA
    Am J Physiol Heart Circ Physiol; 2020 May; 318(5):H1245-H1255. PubMed ID: 32275472
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Does carvedilol have antiarrhythmic properties?
    Naccarelli GV
    Nat Clin Pract Cardiovasc Med; 2005 Jul; 2(7):338-9. PubMed ID: 16265556
    [No Abstract]   [Full Text] [Related]  

  • 77. Antiarrhythmic effect of carvedilol after acute myocardial infarction: results of the Carvedilol Post-Infarct Survival Control in Left Ventricular Dysfunction (CAPRICORN) trial.
    McMurray J; Køber L; Robertson M; Dargie H; Colucci W; Lopez-Sendon J; Remme W; Sharpe DN; Ford I
    J Am Coll Cardiol; 2005 Feb; 45(4):525-30. PubMed ID: 15708698
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Carvedilol saves lives--new data from landmark trials prove survival benefits in heart failure and post myocardial infarction.
    Cardiovasc J S Afr; 2001; 12(2):122-3. PubMed ID: 11474697
    [No Abstract]   [Full Text] [Related]  

  • 79. Randomized active-controlled study comparing effects of treatment with carvedilol versus metoprolol in patients with left ventricular dysfunction after acute myocardial infarction.
    Mrdovic IB; Savic LZ; Perunicic JP; Asanin MR; Lasica RM; Jelena MM; Matic MD; Vasiljevic ZM; Ostojic MC
    Am Heart J; 2007 Jul; 154(1):116-22. PubMed ID: 17584563
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Effect of beta blockers, particularly carvedilol, on reducing the risk of events after acute myocardial infarction.
    Kopecky SL
    Am J Cardiol; 2006 Oct; 98(8):1115-9. PubMed ID: 17027583
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.